Tedizolid Phosphate

泰地唑利磷酸盐

Report date: 2026/05/26 20:00:28
NMEQIDP

Base Information

Drug NameTedizolid Phosphate
Drug Alias Name磷酸泰地唑胺Torezolid phosphate特迪唑烷Tedizolid妥利唑胺 +[19] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Oxazolidinone antibioticsSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of Action50S ribosomal subunit inhibitorsProtein biosynthesis inhibitors
Targets50S ribosomal subunit
Therapy Area/IndicationsAcute bacterial skin and skin structure infectionsDiabetes MellitusRenal Insufficiency +[18] 
Global Approved IndicationsAcute bacterial skin and skin structure infectionsSkin Diseases, BacterialStaphylococcal Infections
Approved Indications in ChinaAcute bacterial skin and skin structure infections
Original Approved Country/TerritoryUnited States
Original Approved Date2014/06/20
Country/TerritoryCzechiaBelgiumBosnia and Herzegovina +[49] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesDong-A Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNabriva Therapeutics PlcMerck Sharp & Dohme CorpMerck Sharp & Dohme Bv +[8] 
Inactive CompaniesBayer Pharma AgTrius Therapeutics IncBayer AG +[8] 
Active IndicationsAcute bacterial skin and skin structure infectionsJoint DiseasesSkin Diseases, Bacterial +[5] 
Inactive IndicationsDiabetes MellitusRenal InsufficiencyHepatic Insufficiency +[13] 

Other Information

ATC CodeJ01XX11
Related LinksWikipediaDrugBankKEGG